Skip to content

PEN · NYSE

Penumbra (PEN) Stock Price & Fundamentals

$312.56+0.21%+$0.64End-of-day price as of Oct 9, 2026

Penumbra (PEN) closed at $312.56 on Oct 9, 2026, up 0.21% from the previous close of $311.92.

Share price, past year

1Y +4.72%

52-week range $251.75 – $316.70. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$312.56
Sep 30, 2026$299.27
Aug 31, 2026$299.89
Jul 31, 2026$294.65
Jun 30, 2026$295.26
May 29, 2026$292.82
Apr 30, 2026$278.42
Mar 31, 2026$256.91
Feb 27, 2026$266.09
Jan 30, 2026$288.81
Dec 31, 2025$285.15
Nov 28, 2025$309.10
Oct 31, 2025$312.81

Key statistics

Market cap
$12.26B
P/E (TTM)
76.8
EPS (TTM)
$4.07
Revenue (TTM)
$1.50B
Net income (TTM)
$160.59M
Shares outstanding
39.2M
Dividend yield
—
52-week range
$251.75 – $316.70

Penumbra's market cap is $12.26B, based on a share price of $312.56 and 39.2M shares outstanding as of Dec 31, 2025.

Financials

Penumbra reported revenue of $1.40B for fiscal 2025, up 17.50% from fiscal 2024.

Penumbra earned net income of $177.69M in fiscal 2025, a net margin of 12.7%.

Fiscal 2025 revenue was the highest in the 10 years shown.

Annual revenue

FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
Penumbra annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Dec 31, 2025$1.40B+17.5%$177.69M12.7%$4.52$174.93M
FY2024ended Dec 31, 2024$1.19B+12.9%$14.01M1.2%$0.36$147.30M
FY2023ended Dec 31, 2023$1.06B+25.0%$90.95M8.6%$2.32$82.12M
FY2022ended Dec 31, 2022$847.13M+13.3%−$2.00M−0.2%−$0.05−$74.96M
FY2021ended Dec 31, 2021$747.59M+33.4%$5.28M0.7%$0.14−$11.68M
FY2020ended Dec 31, 2020$560.41M+2.4%−$15.70M−2.8%−$0.44−$58.00M
FY2019ended Dec 31, 2019$547.41M+23.0%$48.46M8.9%$1.34$4.54M
FY2018ended Dec 31, 2018$444.94M+33.3%$6.60M1.5%$0.18$19.21M
FY2017ended Dec 31, 2017$333.76M+26.8%$4.66M1.4%$0.13$159.00K
FY2016ended Dec 31, 2016$263.32M—$14.81M5.6%$0.44−$26.44M
Penumbra quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q2 FY2026ended Jun 30, 2026$390.05M$34.81M$0.88
Q1 FY2026ended Mar 31, 2026$374.76M$32.58M$0.82
Q4 FY2025ended Dec 31, 2025$385.39M$47.34M$1.20
Q3 FY2025ended Sep 30, 2025$354.69M$45.85M$1.17
Q2 FY2025ended Jun 30, 2025$339.46M$45.27M$1.15
Q1 FY2025ended Mar 31, 2025$324.14M$39.22M$1.00
Q4 FY2024ended Dec 31, 2024$315.52M$33.68M$0.88
Q3 FY2024ended Sep 30, 2024$301.04M$29.53M$0.75

Company profile

Name
Penumbra Inc
Ticker
PEN
Exchange
NYSE
Industry (SEC SIC)
Surgical & Medical Instruments & Apparatus
Headquarters
One Penumbra Place, Alameda, CA 94502
Incorporated in
DE
Fiscal year ends
December
SEC CIK
0001321732

Recent SEC filings

Frequently asked questions

What is Penumbra's stock price?

Penumbra (PEN) closed at $312.56 on Oct 9, 2026, up 0.21% from the previous close of $311.92.

What is Penumbra's market cap?

Penumbra's market cap is $12.26B, based on a share price of $312.56 and 39.2M shares outstanding as of Dec 31, 2025.

How much revenue does Penumbra make?

Penumbra reported revenue of $1.40B for fiscal 2025, up 17.50% from fiscal 2024.

What is PEN's P/E ratio?

Penumbra's price-to-earnings ratio is 76.8, based on trailing twelve-month diluted EPS of $4.07.

Does Penumbra pay a dividend?

Penumbra's recent filings report no dividends declared over the last four quarters.

Sources and methodology

Fundamentals come from Penumbra Inc's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures